Buy Cibinqo (abrocitinib) Online
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Pfizer Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Medicines & Healthcare products Regulatory Agency (MHRA) Cibinqo (abrocitinib) is a tablet taken orally once daily to treat moderate to severe atopic dermatitis in adults and children aged 12 years and older who have not responded well to topical treatments. This medication blocks certain enzymes that cause inflammation and works as a Janus kinase (JAK) inhibitor.
From $1,322.20
Select optionsThis product has multiple variants. The options may be chosen on the product page